Straws are discrete research notes that relate to a particular aspect of the company. Grouped under #hashtags, they are ranked by votes.
A good Straw offers a clear and concise perspective on the company and its prospects.
Please visit the forums tab for general discussion.
“Serko is a technology company that simplifies the complex world of corporate travel management. Serko’s software platform is used by millions of travellers around the world to book and manage their work trips, and by thousands of companies to manage their corporate travel programs.” (blurb from serko.com home page)
“Build the world’s leading business travel marketplace” A big aspiration………………
I did an analysis of Serko when it was listed. My interest was sparked by conversations with a friend in the travel industry who was integrating travel management systems for large corporations and government departments.
Does anyone have user experience with the platform? (My friend has since moved into a different industry)
I held a position back then, but COVID challenged my conviction, and I sold out. I have bought a small research position this week.
Been looking closely at a few software and tech companies that have underperformed recently and in particular the management incentives.
Serko appears to have the most interesting incentives for the CEO as it is revenue based.
Not right in my opinion especially when you are burning cash and still get awarded on the slightest hint of revenue growth.
Should really be EPS based or weighted on the share price performance I think such as Gentrak
Could explain the insider selling recently.
Not sure if I like this one due to this incentive - unless there is an additional condition on the performance that I've missed and someone can point me out on it.
However I know this could go cashflow positive if corporate travel continues to recover.
[held GTK but not this one]
The key Booking.com agreement is up for renewal in May 2024 - the key driver of growth in recent years.
Seems a bit binary (but more likely it will get renewed) but if so and the current economics play out it will tip into profitability (inflection point) in FY25 (absent a world travel disaster - war/recession).
One to watch as could be interesting - especially if Booking.com eventually makes a takeover offer too.
Serko released a Trading Conditions update to the market on the 3rd February 2022.
In the update it advised that:
My thoughts:
Such an update wasn't unexpected given the impact of Omicron so no real surprises. However it does confirm delay on return to revenue growth on pre-COVID levels and continued deep losses and burning through cash. I don't think it really impacts the thesis though and I'd already considered this update in my recent valuation straw.
After the most recent cap raise of NZ$85M and the NZ$52M cash they had at the end of 1HFY22, minus 4 months cash burn of NZ$16M, they should have NZ$121M left.
If they make NZ$20M in revenue in FY22 and burn NZ$48M, so net cash outflow of NZ$28M for the year, which is slightly better than FY21, it means they have 4 years of cash left, if losses don’t widen further. Hopefully they can get to breakeven by that point so they don’t have to raise again although I think that’s most likely a forlorn hope!
The obvious one is COVID. It has had a massive impact on the travel sector, including business travel, with border closures, lockdowns and travel restrictions from both government and private organisations causing business travel to virtually evaporate.
Speaking from personal experience as someone who usually travels a lot for business, I averaged over 50 flights a year pre-COVID but have been reduced to less than 10 per year the past 2 years.
The longer the pandemic goes on the longer Serko’s revenues are suppressed and, as a loss making business, the more cash it burns through. This has already lead to several capital raises and the share count increasing by 30% since the start of the pandemic as Serko raised capital to fund itself. If it goes on for too long Serko may eventually find no one wants to give it any more money. Even if that does not happen, the dilution risk to shareholders is real.
More structurally, the risk is that the North American expansion does not take off. Given the Bull case is based almost entirely on overseas expansion (particularly North America) and it trades on extremely high revenue multiplies with massive growth expectations baked in, if that happens Serko will suffer a brutal re-rate as the market adjusts expectations.
To my mind this is the greater risk than COVID.
6/2/2022: Serko has an oft stated mid-term target of NZ$100M revenue, this would require 4x growth from pre-covid levels (FY20 - ends March 2020) and rely primarily on massive growth in the North American market, as current primary markets of AU and NZ are too small and highly penetrated to achieve this.
I believe that AU + NZ revenue will max out at ~NZ$25M, so in reality, NZ$75M will be required from North America to achieve this, which represents growth of 15x from pre-covid revenue of NZ$4.8 (FY20).
Given the size of the North American market I believe this is achievable so the question becomes, how long will this take?
FY21 and FY22 revenues are both heavily COVID impacted and FY23 will be as well to some extent, which continues to delay a return to the pre-COVID level of business travel, although I’m hopeful FY23 will still see Serko achieve revenue growth on pre-COVID levels.
The business has been investing heavily into the North American market despite COVID (hence the increasing Opex) and currently has 10 TMCs and is in discussions with several large US corporates so I expect revenue to jump out of the gates as business travel recovers.
So with hopefully (COVID depending) some growth in FY23 I am assuming they can reach their NZ$100M revenue target in FY26. This still requires extremely high levels of growth so needs to be watched closely.
Serko currently trades on a 27 - 30 x guided FY22 multiple and was as high as 40!
However, that's too rich for my blood and so at $100M revenue I’ll use a more reasonable 10x multiple (like @Melo’s valuation) to give a market cap of $1 billion. At the current share count (120 million) that works out to a FY26 target of $8.33 per share.
Discounting that back by 15% per year to account for the higher risk level, gives a present value of $4.76 per share.
I hold a small position in RL and think the business has great potential so if it drops to below my idea of fair value I’ll be looking to top up.
Transaction volumes showing positive uplift
Serko Limited (NZX/ASX:SKO), a leader in online travel booking and expense management for business, today provided a trading update, noting that transaction volumes are showing a positive uplift.
Mr Grafton, Serko’s CEO, said: “During March we have seen transaction volumes increase, with transactions month-to-date averaging 68% of the transaction volumes recorded for the same period in March 2019, which were unaffected by Covid-191 . As previously announced, Serko has assumed in its forecasts that travel volumes will be transacting in the range of 40-70% of pre-Covid levels by March 2021, so we are pleased to see transactions currently tracking to the higher end of this range.
“We are also seeing daily transaction volumes reaching their highest rate since Covid started materially impacting Serko’s travel volumes in mid-March 2020, and are pleased to note that some of this uplift is reflective of continued onboarding of new customers in Australasia despite the effects of Covid.
“These positive trends follow ongoing volatility over the past few months as a result of further Covid-related travel restrictions, which saw transaction volumes range from 58% of prior year volumes for the month of December 2020, 40% for January 2021 and 51% for February 2021.”
“We continue to closely monitor travel trends and hope to see these positive trends continue with the vaccination programs underway in key markets and travel restrictions progressively lifting.”
DISC: I Hold
*Numbers in NZD*
Serko is raising up to $55m via a $45m institutional placement and $10m share purchase plan. The placement is underwritten at a floor price of $4.35.
The COVID pandemic has been difficult for Serko, with booking volumes and revenues down by up to 80% in calendar 2020. However, it is also presenting significant opportunities to accelerate growth and take market share while other competitors are struggling. Travel management companies (and their corporate customers) are increasingly using this ‘down’ period to accelerate the shift to Serko’s booking software. This demand has exceeded Serko’s expectations.
Although its current cash balance of ~$33m is likely sufficient to see it through the next 12-24 months, Serko moving from defence to offence and is raising additional capital to take advantage of these opportunities. It will use the funds to:
Interestingly, in the capital raising presentation, Serko notes that it is currently in negotiation for a large direct contract with a US Fortune 500 company. Previously, almost all of Serko’s bookings are done via travel management companies / booking agencies.
Generally, I’m not a fan of capital raisings because they dilute existing shareholders and indicate a business’ inability to fund its own operations. However, this raising appears to be in response to increasing demand for Serko’s booking tools and opportunities within the global travel market – Serko is on the attack. I am likely to participate in the SPP.
Serko has been busy during COVID lockdown, with the highlights being:
— New resellers agreements: Serko has signed new reseller agreements with LUXE Travel Management (July), Acendas Travel (July) and Ovation Travel Group (August). This is great traction for Serko in the North American market. These agreements have been made under Serko’s Community Program – which incentivises resellers to take up Serko’s software platform by accelerating their on-boarding process, deferring implementation fees and not requiring minimum bookings until 2021.
— Awards: Serko was named the New Zealand Hi-Tech Company of the Year 2020. Serko had been nominated as a finalist 8 times before this year, but was yet to win the award. This award has previously been won by Xero (2013, 2015) and Pushpay (2019).
A couple of quotes from travel booking companies that have signed up with Serko:
— LUXE: “Everyone who participated in the testing absolutely loved Zeno compared to the other tools on the market… We also found that Zeno was the platform that was most ready to handle New Distribution Capability (NDC) content. That was important because we all have to prepare for NDC and prepare our travellers for it, too.”
— Acendas Travel: “Zeno is a ground-breaking product that finally gives all parties what they need, whether that’s ease of use for the traveller, control and visibility for the travel manager or rich merchandising for the supplier,” said Acendas SVP, Corporate Travel Joe Curtis. “Particularly with the Zeno expense offering, we foresee this agreement as a way for us to better compete — both in customer retention and acquisition — in competitive bid situations. To top it all off, working with the Serko team has been an incredibly positive experience.”
— Ovation Travel Group: “The level of flexibility and customization available through Zeno is impressive,” said Michael Steiner, Executive Vice President at Ovation. “Because our team at Ovation takes immense pride in providing highly personalized, top-of-the-line service to our clients, offering the Zeno booking and expense solution felt like a natural fit. Zeno’s fresh, user-friendly interface appeals to modern travelers and travel arrangers and at the same time, it’s programmable and flexible enough to meet each client’s unique needs.”
https://www.serko.com/news?submissionGuid=1f8e1506-e517-4b4b-bdc6-5d93f512dd5f
Serko is a SaaS technology business that provides online corporate travel booking and expense management software. The company’s software products include:
Serko sells and delivers its travel booking software through a network of 50+ travel management companies (TMCs) and Online Travel Agents (OTAs), such as American Express Travel, CWT, Orbit Travel and Corporate Travel Management, who in turn provide booking services to their corporate customers incorporating Zeno. Serko then upsells its expense management software directly to these corporates. There are 1,300+ corporate customers using Serko’s software, including (among others) KPMG, PwC, NAB, Siemens, Fonterra, NSW and Queensland Governments and IAG.
Under its current business model, Serko derives revenue in a number of ways:
All revenue streams, except for services revenue, are recurring.
Serko is listed on both the ASX and NZX. The company employs ~200 people worldwide, with headquarters in New Zealand and offices across Australia, China, India and the US. Currently, over $6b of transactions are booked through Serko’s platforms.
Serko’s current strategic focuses are: